En français Research, affordability, and access of medical cannabis are critical issues that must be addressed. September 15, 2017 – Ottawa – As part of their review of cannabis legalization (Bill C-45), the Standing Committee on Health will today hear testimony on the critical needs and concerns regarding the medical use of cannabis. Representatives of…
WATERLOO, ON, JUNE 27, 2017 – Canadians for Fair Access to Medical Marijuana (CFAMM), a national non-profit organization, released a first-of-its-kind preliminary research review on medical cannabis impaired driving – one of the major public safety concerns stemming from the legalization of non-medical cannabis. The review situates the use of cannabis for medical purposes among…
English version here MONTRÉAL, le 20 juin 2017 /CNW/ – Santé Cannabis, le centre d’excellence du cannabis thérapeutique au Québec, et Canadiens pour l’accès équitable à la marijuana médicale (CAEMM), un organisme national à but non lucratif, sont heureux de participer aujourd’hui au forum d’experts sur la légalisation du cannabis. Annoncé par la ministre déléguée…
Aurora Joins CFAMM in Backing Human Rights Case for Medical Cannabis Insurance Coverage En français TORONTO, May 23, 2017 /CNW/ – Canadians for Fair Access to Medical Marijuana (CFAMM) today welcomed a commitment of financial and other resources from licensed producer Aurora Cannabis Inc. in support of Gordon “Wayne” Skinner’s defense in a potentially precedent-setting…
Leading patient advocacy groups applaud federal government’s recognition of medical cannabis within proposed legalization framework Continuation of separate and accessible medical cannabis system is critical; leaves questions about affordability and commitment to research TORONTO, April 13, 2017 – The Arthritis Society and Canadians for Fair Access to Medical Marijuana (CFAMM) welcome the Federal government’ decision…
Nova Scotia: Board Rules in Favour of Insurance Coverage “This landmark human rights commission decision highlights the discrimination patients face when denied coverage for medical cannabis. Although the decision may not extend to all patients or plans, it has the potential to broaden the feasibility of medical cannabis coverage. Armed with this decision, patients will…
